PCD Pharma Franchise Opportunities in Telangana with Daksh Diabetes and Cardiac Care
Recent health data reveals that Telangana is witnessing a rapid and alarming rise in lifestyle diseases, particularly diabetes and hypertension, positioning the state as a major hub for non-communicable diseases. According to the National Family Health Survey (NFHS-6) 2023-24, the prevalence of diabetes in Telangana has increased sharply, with 24.5% of men and 19.6% of women aged 15 and above now having high blood sugar levels or taking medication to control diabetes. This marks a significant spike from the previous NFHS-5 survey (2019-21), where diabetes prevalence stood at 14.7% for women and 19.6% for men.
The burden of hypertension is equally concerning. NFHS-6 found that 29.5% of men and 26.4% of women in Telangana suffer from high blood pressure or take blood pressure medication. Adding to this, the ICMR study on prehypertension found that 28.2% of the population in Telangana is in the prehypertension stage, indicating a massive at-risk group that could develop full-blown hypertension without intervention. The scale of the crisis is further underscored by a massive population-based health screening drive in Telangana, which identified 26.9 lakh people with hypertension and another 14 lakh with diabetes, revealing that a significant portion of the population was unaware of their condition until tested.
The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Telengana families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes.
How Daksh is making a Difference in Telangana
1. Affordable, Quality-Assured Medications
Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment.
What this means for Telangana patients:
- Access to WHO-GMP certified medications
- Lower out-of-pocket expenses for lifelong treatments
- No compromise on quality despite affordable pricing
2. Complete Cardiac Care Portfolio
Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs:
| Product Category | Daksh Offerings | Purpose |
| ACE Inhibitors | DORAPIL (Ramipril) | Blood pressure control, heart failure treatment |
| ARBs | CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) | Hypertension management |
| Beta-Blockers | CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) | Heart rate control, heart failure |
| Calcium Channel Blockers | DUPIN (Amlodipine), CLINITAC (Cilnidipine) | Blood pressure, angina |
| Diuretics | TORDAC (Torsemide), FRUSIDIP | Fluid management in heart failure |
| Lipid Management | ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) | Cholesterol control |
3. Complete Diabetic Care Portfolio
For diabetes management, Daksh provides modern therapeutic options including:
| Product Category | Daksh Offerings |
| SGLT2 Inhibitors | DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug |
| DPP-4 Inhibitors | TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) |
| Sulfonylureas | GLIMIDAC (Glimepiride) |
| Biguanides | GLYCODIP SR (Metformin) |
| Combination Therapies | DYFOZIN M, GLIMIDAC MV (triple combination) |
4. Focus on Preventive Care
Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications:
- Liver tonics for medication-induced liver protection
- Calcium supplements for bone health (critical for diabetic patients)
- Vitamin complexes for overall metabolic support
5. Supporting Healthcare Providers across Telangana
Daksh works with hospitals, clinics, and pharmacies across Telangana to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses.
With the state’s high disease burden, growing healthcare demand, and expanding pharma ecosystem, there is immense potential to build a meaningful healthcare business while serving your community. The PCD model offers monopoly rights, low investment with high profit margins, and comprehensive marketing support, making it an attractive opportunity for aspiring entrepreneurs.
Popular Locations for PCD Pharma Franchise in Telangana
| PCD / Franchise Keywords | Product / Therapy Keywords |
| PCD pharma franchise in Hyderabad | Cardiac diabetic PCD company in Hyderabad |
| PCD pharma franchise in Warangal | Cardiac diabetic products in Warangal |
| PCD pharma franchise in Karimnagar | Diabetic cardiac PCD franchise in Karimnagar |
| PCD pharma franchise in Nizamabad | Cardiac diabetic PCD company in Nizamabad |
| PCD pharma franchise in Khammam | Cardiac diabetic products in Khammam |
| PCD pharma franchise in Ramagundam | Diabetic cardiac PCD franchise in Ramagundam |
| PCD pharma franchise in Mahbubnagar | Cardiac diabetic PCD company in Mahbubnagar |
| PCD pharma franchise in Adilabad | Cardiac diabetic products in Adilabad |
| PCD pharma franchise in Suryapet | Diabetic cardiac PCD franchise in Suryapet |
| PCD pharma franchise in Siddipet | Cardiac diabetic PCD company in Siddipet |
Conclusion
The diabetes and heart disease epidemic in Telangana is not just a statistic it is a reality affecting millions of families. With the state recording a diabetes prevalence of 24.5% among men and 19.6% among women, a hypertension prevalence of 29.5% among men and 26.4% among women, and the hidden epidemic of 26.9 lakh with hypertension and 14 lakh with diabetes uncovered through screening drives, the burden is already immense and growing . But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives.
Daksh Diabetic & Cardiac Care is committed to being part of this solution providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines.
Contact Daksh Diabetic and Cardiac
| Contact Method | Details |
| Office Address | Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India |
| Phone | 📞 +91 93565 60523 📞 +91 78886 02869 |
| enquirypurchase.daksh@gmail.com | |
| Contact us | https://diabetes-cardiac.com/contact-us/ |